Abstract: An error monitoring apparatus and method are provided. The error monitoring method includes collecting an Event-Related Potential (ERP) for at least one passenger in a first mobility for a predetermined amount of time, analyzing the ERP collected for the predetermined amount of time, and transmitting error information of the first mobility to a traffic control server based on a result of analysis. The error information of the first mobility includes at least one of information on a time when the ERP is generated, a waveform of the ERP, position information of the first mobility or operation information of a second mobility, and the second mobility is different from the first mobility and has caused the ERP.
Type:
Application
Filed:
July 8, 2020
Publication date:
January 14, 2021
Applicants:
HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION, Sookmyung Women's University Industry-Academic Cooperation Foundation
Abstract: A mobility controlling method and apparatus based on error monitoring are provided. The mobility controlling method includes: collecting an Event-Related Potential (ERP) for at least one passenger in a mobility for a predetermined time, determining an error factor by analyzing the ERP that is collected for the predetermined time, and performing mobility feedback based on the error factor.
Type:
Application
Filed:
June 19, 2020
Publication date:
December 31, 2020
Applicants:
HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION, SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY- ACADEMIC COOPERATION FOUNDATION
Abstract: A method of inhibiting the growth of cancer stem cells, including administering an effective amount of a protein kinase D1 expression or activity inhibitor as an active ingredient to a subject having cancer is provided. Further, a method of treating cancer, including administering an effective amount of a protein kinase D1 expression or activity inhibitor, and antitumor agent as active ingredients to a subject having cancer is provided. Further, a method for measuring expression or activity of protein kinase D1 for providing information of breast cancer prognosis, including a step of measuring expression or activity of protein kinase D1 in cells or tissues isolated from a subject is provided.
Type:
Grant
Filed:
June 8, 2017
Date of Patent:
April 21, 2020
Assignee:
SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
Inventors:
Jong Hoon Park, Do Yeon Kim, Eun Young Park, Kyung-Hee Chun, Eun Ji Lee, Eun Sun Chang, Hyeok-Gu Kang